The predictability of T3disease in staging MRI following prostate biopsy decreases in patients with high initial PSA and Gleason score

Asian Journal of Andrology

Volumn 13, Issue 3, 2011, Pages 487-493

  Hwii Ko, Young ^a   Jae Sung, Deuk ^a   Gu Kang, Sung ^a   Ho Kang, Seok ^a   Gu Lee, Jeong ^a   Jong Kim, Je ^a   Cheon, Jun ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

magnetic resonance imaging; neoplasm staging; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; EXTRACAPSULAR EXTENSION; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; ROBOTICS; SEMINAL VESICLE; SEMINAL VESICLE INVASION; SENSITIVITY AND SPECIFICITY; BIOPSY; CANCER INVASION; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PROSTATE; PROSTATE TUMOR; UROLOGIC SURGERY;

AGED; BIOPSY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; ROBOTICS; SENSITIVITY AND SPECIFICITY; UROLOGIC SURGICAL PROCEDURES;

EID: 79955667690     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1038/aja.2010.165     Document Type: Article

References (35)

1. Borley N, Feneley MR. Prostate cancer: diagnosis and staging. Asian J Androl 2009; 11: 74-80.
2. Wang L, Mullerad M, Chen HN, Eberhardt SC, Kattan MW et al. Prostate cancer:incremental value of endorectal MR imaging findings for prediction of extracapsular extension. Radiology 2004; 232: 133-9. (Pubitemid 38787828)
3. Wang L, Hricak H, Kattan MW, Schwartz LH, Eberhardt SC et al. Combinedendorectal and phased-array MRI in the prediction of pelvic lymph node metastasis in prostate cancer. Am J Roentgenol 2006; 186: 743-8. (Pubitemid 46100258)
4. Wang L, Hricak H, Kattan MW, Chen H, Scardino PT. Prediction of prostate cancer organ-confined disease: the incremental valueof endorectal coil magnetic resonance imagingto partin staging nomograms (2001version). Radiology 2006; 238: 597-603.
5. White S, Hricak H, Forstner R, Kurhanewicz J, Vigneron DB et al. Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. Radiology 1995; 195: 385-90.
6. Fuchsjäger M, Shukla-Dave A, Akin O, Barentsz J, Hricak H. Prostatecancer imaging. Acta Radiol 2008; 49: 107-20.
7. Ikonen S, Kivisaari L, Vehmas T, Tervahartiala P, Salo JO et al. Optimal timingof post-biopsy MR imagingof the prostate. Acta Radiol 2001; 42: 70-3. (Pubitemid 33630131)
8. Sommer FG, Nghiem HV, Herfkens R, Mc Neal J, Low RN. Determiningthevolumeof prostatic carcinoma: value of MR imaging with an external-array coil. AJR Am J Roentgenol 1993; 161: 81-6. (Pubitemid 23208753)
9. Chelsky MJ, Schnall MD, Seidmon EJ, Pollack HM. Use of endorectal surface coil magnetic resonance imagingfor local staging of prostatecancer. J Urol 1993; 150: 391-5. (Pubitemid 23215877)
10. Gronau E, Goppelt M, Harzmann R, Weckermann D. Prostate cancer relapse after therapy with curative intention: a diagnostic and therapeutic dilemma. Onkologie 2005; 28: 361-6. (Pubitemid 40827493)
11. Fütterer JJ.MR imaging in local staging of prostate cancer. Eur J Radiol 2007; 63: 328-34. (Pubitemid 47321041)
12. Qayyum A, Coakley FV, Lu Y, Olpin JD, Wu L et al. Organ-confined prostate cancer: effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imaging. AJR Am J Roentgenol 2004; 183: 1079-83. (Pubitemid 44185100)
13. Rørvik J, Halvorsen OJ, Albrektsen G, Ersland L, Daehlin L et al. MRI with an endorectal coil for staging of clinically localised prostate cancer prior to radical prostatectomy. Eur Radiol 1999; 9: 29-34.
14. Payne H. Management of locallyadvanced prostatecancer. Asian J Androl 2009; 11: 81-7.
15. Epstein JI, Amin M, Boccon-Gibod L, Egevad L, Humphrey PAet al. Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenect omyspecimens. Scand J Urol Nephrol Suppl 2005; 216: 34-63.
16. Ellis JH, Tempany C, Sarin MS, Gatsonis C, Rifkin MD et al. MR imaging and sonography of early prostatic cancer: pathologic and imaging features that influence identification and diagnosis. AJR Am J Roentgenol 1994; 162: 865-72. (Pubitemid 24115872)
17. Ikonen S, Kärkkäinen P, Kivisaari L, Salo JO, Taari K et al. Magnetic resonance imaging of prostatic cancer: does detection vary between high and low Gleason score tumors? Prostate 2000; 43: 43-8. (Pubitemid 30164242)
18. Puech P, Potiron E, Lemaitre L, Leroy X, Haber GPet al. Dynamiccontrast-enhanced-magnetic resonance imaging evaluation of intraprostatic prostate cancer: correlation with radical prostatectomyspecimens. Urology 2009; 74: 1094-9.
19. Lee HW, Seo SI, Jeon SS, Lee HM, Choi HY. Can we predict real T3 stage prostate cancer in patientswithclinical T3 (cT3)diseasebeforeradical prostatectomy? Yonsei Med J2010; 51: 700-7.
20. Ikonen S, Kivisaari L, Vehmas T, Tervahartiala P, Salo JOet al. Optimaltimingof post-biopsy MR imaging of the prostate. Acta Radiol 2001; 42: 70-3.
21. Hara N, Okuizumi M, Koike H, Kawaguchi M, Bilim V. Dynamic contrast-enhanced magnetic resonance imaging(DCE-MRI) isa useful modalityfortheprecisedetection and staging of early prostatecancer. Prostate 2005; 62: 140-7. (Pubitemid 40096780)
22. Ahmed HU, Kirkham A, Arya M, Illing R, Freeman Aet al. Isittimetoconsiderarolefor MRI before prostate biopsy? Nat Rev Clin Oncol 2009; 6: 197-206.
23. Oehr P, Bouchelouche K. Imaging of prostatecancer. Curr Opin Oncol 2007; 19: 259-64.
24. Carey BM. Imagingfor prostate cancer. Clin Oncol 2005; 17: 553-9.
25. Kurhanewicz J,Vigneron DB, Males RG, Swanson MG, Yu KKet al. Theprostategland: a clinically relevant approach to imaging. Radiol Clin North Am 2000; 38: 116-38.
26. Engelbrecht MR, Jager GJ, Laheij RJ, Verbeek AL, van Lier HJ et al. Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis. Eur Radiol 2002;12:2294-302. (Pubitemid 36940327)
27. Outwater EK, Petersen RO, Siegelman ES, Gomella LG, Chernesky CE et al. Prostate carcinoma: assessment of diagnostic criteria for capsular penetration on endorectal coil MR images. Radiology 1994; 193: 333-9. (Pubitemid 24338310)
28. Dhingsa R, Qayyum A, Coakley FV, Lu Y, Jones KD et al. Prostate cancer localization with endorectal MR imagingand MR spectroscopic imaging: Effect of clinical data on reader accuracy. Radiology 2004; 230: 215-20. (Pubitemid 37549804)
29. Jager GJ, Ruijter ET, van de Kaa CA, de la Rosette JJ, Oosterhof GOet al. Localstaging of prostate cancer with endorectal MR imaging: correlation with histopathology. AJR Am J Roentgenol 1996; 166:845-52. (Pubitemid 26102064)
30. Mirowitz SA. Seminal vesicles: biopsy-related hemorrhagesimulatingtumor invasion atendorectal MR imaging. Radiology 1992; 185: 373-6.
31. Tamada T, Sone T, Jo Y, Yamamoto A, Yamashita T et al. Prostatecancer: relationships between postbiopsy hemorrhageand tumor detectabilityat MR diagnosis. Radiology 2008; 248: 531-9.
32. Choi YJ, Kim JK, Kim N, Kim KW, Choi EK et al. Functional MR imaging of prostate cancer. Radiographics 2007; 27: 63-75.
33. Turkbey B, Albert PS, Kurdziel K, Choyke PL Imaging localized prostate cancer: current approaches and new developments. AJR Am J Roentgenol 2009; 192: 1471-80.
34. Lee SH, Park KK, Choi KH, Lim BJ, Kim JH et al. Isendorectal coil necessaryforthe staging of clinically localized prostate cancer? Comparison of non-endorectal versus endorectal MR imaging. World J Urol 2010; 28: 667-72.
35. Brajtbord JS, Lavery HJ, Nabizada-Pace F, Senaratne P, Samadi DB. Endorectal magnetic resonance imaging has limited clinical abilityto preoperatively predict pT3 prostate cancer. BJU Int; e-pub ahead of print 26 August 2010; doi: 10.1111/j.1464-410X.2010.09599.x.